TrademarkDir
EXONEUROGENESIS
DEAD

Serial Number

88757965

Owner

Cygnal Therapeutics, Inc.

Attorney

Christina M. Licursi

Filing Date

Jan 14, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EXONEUROGENESIS Trademark

Serial Number: 88757965

EXONEUROGENESIS is a trademark filed by Cygnal Therapeutics, Inc. on January 14, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cygnal Therapeutics, Inc. (9 trademarks)

325 Vassar Street, Suite 2B
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

January 14, 2020

Registration Date

Not Registered

Published for Opposition

November 10, 2020

Goods & Services

scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; pharmaceutical preparations for the treatment of cancer and immune system related diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 8, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 8, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jan 4, 2022 EX2G
SOU EXTENSION 2 FILED
Jan 4, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 6, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jul 3, 2021 EX1G
SOU EXTENSION 1 FILED
Jul 3, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 3, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2021 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 5, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 12, 2020 AMPX
ASSIGNED TO LIE
Feb 10, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 5, 2020 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2020 NWOS

Related Trademarks

More from this Owner

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

CYGNAL THERAPEUTICS

CYGNAL THERAPEUTICS

EMP

EMP